Mount Sinai National Jewish Health Respiratory Institute

Search results

• Weekly: Kalvista Pharmaceuticals (KALV: $11.89) falls 6% on firm volume, Cash Runway of 11 months; -71c [5.6%] Vol Index 1.3 [1 is avg]

  Busse, P.

  22/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $12.60) keeps rising: up 61% in 9 weeks; +68c [5.7%]

  Busse, P.

  15/03/25

  1 item of Media coverage

  Press/Media

• Kalvista Pharmaceuticals continues uptrend, surges 45% and in top 3% of the market

  Busse, P.

  14/03/25

  1 item of Media coverage

  Press/Media

• The best wedge pillows that make back sleeping more comfortable

  Varga, A.

  10/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Kalvista Pharmaceuticals (KALV: $11.92) keeps rising: up 52% in 8 weeks; +52.5c [4.6%] Vol Index 1.7 [1 is avg]

  Busse, P.

  8/03/25

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting

  Busse, P.

  4/03/25

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting

  Busse, P.

  3/03/25

  11 items of Media coverage

  Press/Media

• CPAP therapy may not improve neurocognition for some people with obstructive sleep apnea

  Varga, A.

  21/02/25

  1 item of Media coverage

  Press/Media

• U.S. Patents Awarded to Inventors in New York (Feb. 12)

  Ayappa, I.

  12/02/25

  1 item of Media coverage

  Press/Media

• System and Method for Automated Titration of Continuous Positive Airway Pressure Using an Obstruction Index

  Ayappa, I.

  11/02/25

  1 item of Media coverage

  Press/Media

• CPAP Therapy More Effective in Minimizing Neurocognitive Effects in OSA Patients with a Higher Arousal Threshold

  Varga, A.

  10/02/25

  1 item of Media coverage

  Press/Media

• Researcher at Columbia University Mailman School of Public Health Details Research in Hypertension (Racism and Postpartum Blood Pressure in a Multiethnic Prospective Cohort)

  Janevic, T., Lee, A. & McCarthy, K.

  7/02/25

  1 item of Media coverage

  Press/Media

• Why Doctors Still Recommend Masking After Wildfire Smoke Clears

  Bose, S.

  14/01/25

  1 item of Media coverage

  Press/Media

• Lung Health Experts Warn of Dangers of Wildfire Smoke Exposure

  Lee, A.

  11/01/25

  1 item of Media coverage

  Press/Media

• Division of Pulmonary Researcher Releases New Data on Obstructive Sleep Apnea (Beyond CPAP for Cardiovascular Risk Reduction in Patients with OSA)

  Kundel, V.

  8/01/25

  1 item of Media coverage

  Press/Media

• How to Stop Doomscrolling (Because, Yes, It’s Pretty Bad for Your Health)

  Varga, A.

  26/12/24

  3 items of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Reports Findings in Anxiety Disorders (Clinical Characteristics of Patients With COPD and Comorbid Depression and Anxiety: Data From a National Multicenter Cohort Study)

  Bose, S.

  16/12/24

  1 item of Media coverage

  Press/Media

• Researchers at Icahn School of Medicine at Mount Sinai Publish New Study Findings on Health and Medicine [Implementation and Assessment of a Curriculum for Renal Point of Care Ultrasound (POCUS) Training]

  Ishisaka, Y., Patrawalla, P. & Charen, E.

  4/12/24

  1 item of Media coverage

  Press/Media

• Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

  Busse, P.

  25/10/24

  2 items of Media coverage

  Press/Media

• Intellia Therapeutics Inc to review the NTLA2002 Phase 2 data - Final

  Busse, P.

  24/10/24

  1 item of Media coverage

  Press/Media

• Intellia Presents Positive Results From The Phase 2 Study Of NTLA-2002, An Investigational In Vivo CRISPR Gene Editing Treatment For Hereditary Angioedema (HAE)

  Busse, P.

  24/10/24

  16 items of Media coverage

  Press/Media

• Intellia data spark debate about CRISPR drug’s potential

  Busse, P.

  24/10/24

  1 item of Media coverage

  Press/Media

• Intellia Presents Positive Results From The Phase 2 Study Of NTLA-2002, An Investigational In Vivo CRISPR Gene Editing Treatment For Hereditary Angioedema (HAE)

  Busse, P.

  24/10/24

  1 item of Media coverage

  Press/Media

• REGAIN: Real World and Genomic Data Based Asthma Insight Through Network Analysis

  Hao, K. & Rogers, L.

  15/10/24

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researchers Provide New Study Findings on Ecotoxicology and Environmental Safety (Prenatal exposure to PM2.5 led to impaired respiratory function in adult mice)

  Chen, J., Hao, K., Zhang, Z. & Rogers, L.

  9/10/24

  1 item of Media coverage

  Press/Media